Company: MYSZ
Filing Date: 2025-07-08
Form Type: DEF 14A
Source: 0001641172-25-018202
Chunk: 29

Company: My Size, Inc.
Filing Date: 2025-07-08
Form: DEF 14A
Chunk 29
---
 |      - |    |     |                   |       - |
|                                                                |     |                                                                 |   - |    |     |                                                                   | - |     |                       |    - |    |     |                        | -         |     |                  | 19,750 | -5 |     | $                 |  84,333 |
| Billy Pardo- Chief Operating Officer and Chief Product Officer |     |                                                                 |     |    |     |                                                                   |   |     |                       |      |    |     |                        |           |     |                  |        |    |     |                   |         |
|                                                                |     |                                                                 | 650 | -2 |     |                                                                   | - |     | $                     | 8.72 | -6 |     |                        | 8/10/2025 |     |                  |      - |    |     |                   |       - |
|                                                                |     |                                                                 |   - |    |     |                                                                   | - |     |                       |    - |    |     |                        | -         |     |                  | 19,750 | -6 |     | $                 |  84,333 |

* On June 4, 2025, our compensation committee reduced the exercise price of outstanding options of certain of our employees, officers and directors for the purchase of an aggregate of 13,926 shares of common stock (with exercise prices ranging from $3.832 to $8.72 per Share) to $1.28 per Share, which was the closing price of our common stock on the Nasdaq Capital Market on June 4, 2025. The exercise price reduction included options held by, among others, the Company’s named executive officers with respect to the following number of shares of common stock: (i) Ronen Luzon, our Chief Executive Officer and director: 800 shares, (ii) Or Kles, our former Chief Financial Officer: 650 shares, and (iii) Billy Pardo, our Chief Operating Officer and Chief Product Officer: 650 shares.

** Effective March 31, 2025, Mr. Kles resigned as Chief Financial Officer and effective April 1, 2025, Mr. Elmaliah was appointed Chief Financial Officer.

(1) The option has a grant date of October 8, 2020, 200 options vested on November 26, 2020, 200 options vested on May 26, 2021, 200 options vested on